Cases 51 - 60 of 146
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries, Ltd. et al
as 1:2017cv00970
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Taro Pharmaceutical Industries, Ltd. , Taro Pharmaceuticals U.S.A., Inc. and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Bayer Intellectual Property GmbH et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00584
Plaintiff:
Bayer Intellectual Property GmbH , Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00389
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Novartis AG and Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc.
as 1:2017cv00379
Plaintiff:
Bristol-Myers Squibb Company and Pfizer Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Mylan Technologies, Inc. et al
as 1:2017cv00322
Plaintiff:
UCB, Inc. , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Defendant:
Mylan Technologies, Inc. , Mylan Pharmaceuticals, Inc. and Mylan, Inc.
Counter_claimant:
Mylan Pharmaceuticals, Inc. , Mylan Technologies, Inc. and Mylan, Inc.
Counter_defendant:
LTS Lohmann Therapie-Systeme AG , UCB Manufacturing Ireland Limited , UCB Pharma GmbH and others
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00249
Plaintiff:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd. and Teva Neuroscience, Inc.
Defendant:
Mylan Pharmaceuticals Inc. , Mylan Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Gilead Sciences, Inc. v. Mylan Pharmaceuticals Inc.
as 1:2017cv00187
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00113
Plaintiff:
Amgen Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan Pharmaceuticals Inc. et al
as 1:2017cv00024
Plaintiff:
Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals USA, Inc. et al v. Doctor Reddys Laboratories, Ltd. et al
as 1:2016cv01267
Plaintiff:
Teva Pharmaceuticals USA, Inc. , Teva Pharmaceutical Industries Ltd , Teva Neuroscience, Inc. and others
Defendant:
Doctor Reddys Laboratories, Ltd., Doctor Reddys Laboratories, Inc., Sandoz, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
